FEATURED/ARCHIVES (08/05/24)
×
Effort-Cost Decision-Making among Individuals with Schizophrenia: A Systematic Review and Meta-Analysis · April 2023
Abstracts
JAMA Psychiatry
×
Paliperidone-Associated Sialorrhea: A Case Report with Review of Current Literature · September 2022
Abstracts
Journal of Clinical Psychopharmacology
×
Pimavanserin Treatment of Hallucinations and Delusions in Patients with Parkinson’s Disease Dementia: Post Hoc Analysis of the HARMONY Trial (Meetings-Events) · May 2022
Abstracts
Neurology
×
Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents with Psychosis Treated with Aripiprazole or Quetiapine: Results from the TEA Trial · January 2022
Abstracts
Journal of the American Academy of Child and Adolescent Psychiatry
×
Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia · May 2023
Abstracts
Journal of Clinical Psychopharmacology
×
Clozapine Combination and Augmentation Strategies in Patients with Schizophrenia -Recommendations from an International Expert Survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Efficacy of a Gluten-Restricted Diet in Treatment-Resistant Schizophrenia Patients with Immunological Gluten Sensitivity: A Case Report · January 2022
Abstracts
Schizophrenia Research
×
Ultra-Resistant Schizophrenia Is Associated with a Delay to Initiate Clozapine and with Less Abdominal Obesity: Sex Differences in Insulinemia and Leptin Levels Are Observed between Responders and Not Responders (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
When to Use Amisulpride in Adolescents: A Retrospective Chart Examination of Inpatients · May 2022
Abstracts
Journal of Clinical Psychopharmacology
×
Antipsychotic Use and Bloodstream Infections among Adult Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study · April 2021
Abstracts
Journal of Clinical Psychiatry
×
Effect of Brexpiprazole on Engagement in Patients with Schizophrenia: Post-Hoc Analysis of Three Studies (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Relationship of Family Genetic Risk Score with Diagnostic Trajectory in a Swedish National Sample of Incident Cases of Major Depression, Bipolar Disorder, Other Nonaffective Psychosis, and Schizophrenia · January 2023
Abstracts
JAMA Psychiatry
×
Long-Term Treatment with Long-Acting Injectable Antipsychotic in Schizophrenia Patients with and without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative Study · July 2022
Abstracts
Journal of Clinical Psychopharmacology
×
Efficacy and Safety of Aripiprazole Once-Monthly versus Oral Aripiprazole in Chinese Patients with Acute Schizophrenia: A Multicenter, Randomized, Double-Blind, Non-Inferiority Study · January 2022
Abstracts
Psychopharmacology
×
Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients with Treatment-Resistant Schizophrenia · March 2023
Abstracts
Journal of Clinical Psychopharmacology
×
Effectiveness of Orally Administered Co-Enzyme Q10 for Schizophrenia: Cognitive, Functional and Biochemical Outcomes from a Double Blind, Randomised, Placebo Controlled Trial (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Antipsychotics and Risk of QT Prolongation: A Pharmacovigilance Study · December 2022
Abstracts
Psychopharmacology
×
Safety Profile of Adjunctive Pimavanserin in the ENHANCE Study, a Phase 3 Trial for the Potential Treatment of Schizophrenia in Patients with an Inadequate Response to Antipsychotic Treatment (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Glutamate and Response to Clozapine in Treatment Resistant Schizophrenia (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Pro-Inflammatory Cytokine Levels Are Elevated in Female Patients with Schizophrenia Treated with Clozapine · January 2022
Abstracts
Psychopharmacology